MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202611000432 A) filed by Ct University, Ludhiana, Punjab, on Jan. 2, for 'neutraceutical gummies of syzygium cumini and process thereof.'
Inventor(s) include Dr. Nitin Tandon; Rinka Juneja; Amritpal Singh; Jyotika Rani; Dr. Ashish Raina; and Priyanka Bhandari.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "Jamun (Syzygium cumini) gummies with zinc offer a unique combination of natural phytochemicals and an essential micronutrient, making them a functional and consumer-friendly nutraceutical. Jamun is rich in antioxidants such as anthocyanins, flavonoids, and polyphenols, which help reduce oxidative stress and support immune health. When combined with zinc, a mineral crucial for immune function, wound healing, DNA synthesis, and enzyme activity, the formulation provides synergistic benefits for overall wellness. Jamun gummies are especially beneficial for blood sugar management, as jamun is traditionally known for its hypoglycemic properties, making them suitable for people with metabolic concerns when formulated with low sugar or sugar substitutes. Zinc enhances immunity, supports growth and development, and improves taste perception, which can be compromised during deficiency. The gummy format improves compliance, particularly among children and elderly consumers who may dislike tablets or capsules. Additionally, plant-based jamun gummies align well with clean-label, vegan, and natural nutraceutical trends, enhancing market acceptance."
Disclaimer: Curated by HT Syndication.
